hs-CRP (High Sensitivity C-Reactive Protein)
High-sensitivity CRP detects low levels of C-reactive protein, an acute phase protein produced by the liver in response to inflammatory cytokines. It independently predicts cardiovascular events even when cholesterol is normal, with values below 1 mg/L considered low risk and above 3 mg/L high risk. Levels are reduced by weight loss, exercise, improved diet, and statin therapy.
Units: mg/L; some labs report mg/dL (mg/dL = mg/L ÷ 10). Check the units on your report before comparing to any range here.
Optimal range: who says what
Institutions, researchers and practitioners draw the line in different places. Each position is listed with who holds it and, where a document states it, a link. How we verify ranges.
- Institution or study<1.0 mg/L low risk; 1-3 average; >3 highAHA/CDC scientific statement on inflammatory markers (2003)
- Institution or study≥2.0 mg/L is a risk-enhancing factor2018 AHA/ACC cholesterol guidelineUsed to refine a borderline or intermediate 10-year risk estimate
- Named practitioner<0.5 mg/L (optimal), <1 mg/L (low risk)Optimal DX · Biomarkers of Inflammation: High-Sensitivity CRP
- Named practitioner<1.0 mg/L (lower is generally better)Life Extension · Lab Testing Protocol (Suggested Optimal Ranges)Disclosure: Life Extension sells lab panels that appear in our blood-test comparisons.
- Named practitioner<1.0 mg/LTracey O'Shea (Kresser Institute) · The Lipid Panel Was Fine. The Patient Was Not: A Case in Advanced Cardiovascular Risk Assessment
- Lab reference intervalLow risk: <1.0 mg/L, Average risk: 1.0-3.0 mg/L, High risk: >3.0 mg/L (Labcorp, CDC/AHA)What a lab report flags against. A lab interval is not an optimal target.
Practitioner targets are individual positions, often tighter than guideline ranges. Each was checked against its article before publishing.
20 of 21 itemized panels
Inflammation & Immune Markers
What is hs-CRP (High Sensitivity C-Reactive Protein)?
High-sensitivity C-reactive protein (hs-CRP) is an acute-phase inflammatory protein produced by the liver in response to inflammation anywhere in the body. Unlike standard CRP tests used to detect acute infections or severe inflammation, hs-CRP measures very low levels of chronic, low-grade inflammation that is strongly associated with cardiovascular disease, metabolic dysfunction, and accelerated aging.
CRP is part of the innate immune system and rises rapidly (within hours) in response to tissue injury, infection, or inflammatory stimuli. The high-sensitivity assay can detect CRP levels as low as 0.1 mg/L, making it useful for cardiovascular risk stratification in apparently healthy individuals. Elevated hs-CRP indicates systemic inflammation, which contributes to atherosclerotic plaque formation, instability, and rupture.
Beyond cardiovascular disease, chronic low-grade inflammation (reflected by elevated hs-CRP) is implicated in type 2 diabetes, metabolic syndrome, obesity, depression, cognitive decline, and cancer. Reducing hs-CRP through lifestyle interventions and medications is associated with improved cardiovascular outcomes, making it both a risk marker and a potential therapeutic target.
Why hs-CRP Is A Critical Inflammatory Marker
- Predicts cardiovascular events independently of cholesterol levels—even people with "normal" LDL can have elevated hs-CRP indicating residual inflammatory risk
- Identifies "residual inflammatory risk" after statin therapy—many heart attacks occur in patients with well-controlled LDL but persistent inflammation
- Reflects systemic inflammation from visceral fat, poor diet, sedentary lifestyle, chronic infections, and autoimmune conditions
- Responds to lifestyle interventions (weight loss, exercise, Mediterranean diet) within weeks, providing actionable feedback
- Guides statin therapy decisions in intermediate-risk patients—the JUPITER trial showed statins benefit people with elevated hs-CRP even with normal LDL
- Tracks effectiveness of anti-inflammatory interventions and metabolic health improvements over time
Interpretation bands (curated, PMID-backed)
Holder: OptimizeBiomarkers editorial synthesis of: Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis (Li et al., 2017); Dose-response association between C-reactive protein and risk of all-cause and cause-specific mortality: a systematic review and meta-analysis of cohort studies (Ni et al., 2020). No single paper sets these cutoffs; for attributed targets see who says what.
Low Risk<1.0 mg/L▼
- Indicates minimal systemic inflammation and lowest cardiovascular risk
- This is the target range for optimal metabolic health
- Achieved through healthy body composition, regular exercise, anti-inflammatory diet, adequate sleep, and stress management
- Some individuals maintain hs-CRP <0.5 mg/L with excellent lifestyle habits
Moderate Risk1.0-3.0 mg/L▼
- Indicates mild chronic inflammation and intermediate cardiovascular risk
- Common in overweight individuals, those with sedentary lifestyles, or early metabolic dysfunction
- Warrants lifestyle optimization and monitoring
- If persistent despite lifestyle changes, consider screening for occult infections, autoimmune conditions, or periodontal disease
Very Low<0.3 mg/L▼
- Very low hs-CRP is not concerning and indicates excellent control of systemic inflammation
- Some elite athletes and individuals with exceptional metabolic health achieve these levels
- No intervention needed
High Risk>3.0 mg/L▼
- Indicates significant chronic inflammation and elevated cardiovascular risk (2-3x higher than low-risk individuals)
- Requires comprehensive evaluation for underlying causes: obesity, metabolic syndrome, diabetes, periodontal disease, chronic infections, autoimmune conditions
- If >10 mg/L, suggests acute inflammation (infection, injury) rather than chronic low-grade inflammation—retest in 2-3 weeks after acute cause resolves
- Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis.
- A Systematic Review and Meta-Analysis of Advanced Biomarkers for Predicting Incident Cardiovascular Disease among Asymptomatic Middle-Aged Adults.
- Dose-response association between C-reactive protein and risk of all-cause and cause-specific mortality: a systematic review and meta-analysis of cohort studies.
What raises or lowers hs-CRP
Causes of high hs-CRP
- Obesity, especially visceral/abdominal fat (most common cause)
- Metabolic syndrome and insulin resistance
- Type 2 diabetes
- Smoking (raises hs-CRP)
- Sedentary lifestyle
- Poor diet (high sugar, refined carbs, processed foods, trans fats)
- Chronic infections: Periodontal disease, H. pylori, chronic sinusitis
- Autoimmune conditions: Rheumatoid arthritis, lupus, IBD
- Sleep disorders: Obstructive sleep apnea, chronic sleep deprivation
- Chronic stress and depression
- Hormone imbalances: Low testosterone, hypothyroidism
- Certain medications: Hormone replacement therapy, oral contraceptives
Causes of low hs-CRP
- Excellent metabolic health and body composition
- Regular exercise and physical activity
- Anti-inflammatory diet (Mediterranean, whole foods)
- Adequate sleep and stress management
- Absence of chronic infections or autoimmune conditions
- Genetic factors (some people naturally have lower inflammatory responses)
Symptoms when hs-CRP is high or low
When high
- Fatigue and low energy (chronic inflammation is metabolically demanding)
- Brain fog and difficulty concentrating
- Joint pain and stiffness (especially morning stiffness)
- Frequent infections or slow recovery from illness
- Mood changes: Depression, anxiety, irritability
- Poor exercise recovery
- Unexplained weight gain or difficulty losing weight
- Skin issues: Acne, eczema flares, slow wound healing
These symptoms are non-specific and can have many causes. However, persistent fatigue with elevated hs-CRP should prompt investigation for underlying inflammatory conditions. Many people with elevated hs-CRP are asymptomatic, which is why testing is valuable for identifying hidden inflammation.
How to move hs-CRP
Effect sizes (how much something moves the marker) appear only where the paper cited under the item states them. Talk to your clinician before starting or changing any medication or supplement.
Weight Loss and Body Composition
- Visceral fat is highly inflammatory and a major driver of elevated hs-CRP. Losing excess body fat lowers hs-CRP. Focus on reducing waist circumference (<40 inches for men, <35 inches for women). Caloric restriction, intermittent fasting, and low-carbohydrate diets are effective. Each 1 kg of weight loss reduces hs-CRP by approximately 0.13 mg/L.
- Resistance training builds metabolically active muscle and reduces inflammatory adipokines. Combine with moderate caloric deficit for optimal results.
Anti-Inflammatory Diet
- A Mediterranean-style diet has lowered hs-CRP in trials. Key components: fatty fish 2-3x/week (salmon, sardines, mackerel), extra virgin olive oil (2-4 tbsp daily), vegetables (especially leafy greens), nuts (walnuts, almonds), berries, and whole grains.
- Eliminate or reduce: Refined carbohydrates, sugar-sweetened beverages, processed meats, trans fats, and excessive omega-6 vegetable oils. These promote inflammation through advanced glycation end products (AGEs), oxidative stress, and gut dysbiosis.
Regular Exercise
- Both aerobic and resistance exercise reduce hs-CRP independently of weight loss. The Physical Activity Guidelines for Americans call for at least 150 minutes/week of moderate-intensity aerobic activity (brisk walking, cycling, swimming) plus muscle-strengthening work on 2 or more days. Exercise reduces inflammation through multiple mechanisms: improved insulin sensitivity, reduced visceral fat, enhanced antioxidant defenses, and anti-inflammatory myokines released from contracting muscle.
- High-intensity interval training (HIIT) may be particularly effective. Avoid overtraining, which can temporarily elevate CRP.
Sleep and Stress Management
- Poor sleep (<6 hours/night) and chronic stress elevate cortisol and inflammatory cytokines, raising hs-CRP. The National Sleep Foundation recommends 7-9 hours for adults. Address sleep apnea if present—untreated OSA significantly elevates hs-CRP and cardiovascular risk.
- Practice stress reduction: Meditation, deep breathing, yoga, time in nature. Chronic psychological stress activates the HPA axis and sympathetic nervous system, promoting systemic inflammation. Even 10-15 minutes of daily meditation can measurably reduce hs-CRP over 8-12 weeks.
Targeted Supplements and Medications
- Omega-3 fatty acids (EPA+DHA): 2-4 g daily may lower hs-CRP modestly. Use high-quality fish oil or algae-based supplements.
- Curcumin: 500-1000mg daily (with piperine for absorption) has lowered CRP in small trials.
- Statins: In JUPITER, rosuvastatin lowered LDL cholesterol by 50% and hs-CRP by 37% in people with elevated hs-CRP and LDL below 130 mg/dL (Ridker 2008). Consider if hs-CRP persistently >2 mg/L with cardiovascular risk factors.
- Aspirin: Low-dose (81-100mg) may reduce hs-CRP modestly; discuss with physician if high cardiovascular risk.
- Address underlying causes: Treat periodontal disease, eradicate H. pylori if present, optimize thyroid function, manage autoimmune conditions.
Source: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
When to retest
- Baseline: Check hs-CRP as part of cardiovascular risk assessment, especially if family history of heart disease, metabolic syndrome, or intermediate Framingham risk score.
- After lifestyle intervention: Retest 8-12 weeks after starting weight loss, exercise program, or dietary changes.
- If acutely elevated (>10 mg/L): Retest in 2-3 weeks after acute illness/injury resolves. Chronic low-grade inflammation should be distinguished from acute inflammation.
- Annual monitoring: If previously elevated, check annually to track progress. If consistently <1 mg/L, less frequent testing is reasonable.
- After starting statin: Retest 6-12 weeks after initiation. In JUPITER, rosuvastatin lowered hs-CRP by 37% (Ridker 2008). Persistent elevation despite statin suggests residual inflammatory risk requiring additional interventions.
- With other inflammatory markers: Consider checking along with fibrinogen, IL-6, or ferritin for comprehensive inflammatory assessment if hs-CRP persistently elevated without clear cause.
Scientific Evidence
hs-CRP and Coronary Risk
A systematic review for the US Preventive Services Task Force found CRP above 3.0 mg/L associated with a relative risk of 1.58 for coronary heart disease compared with CRP below 1.0 mg/L, after adjusting for Framingham risk factors. Adding CRP improved risk stratification in intermediate-risk people, but evidence that lowering CRP prevents events was lacking.
JUPITER Trial: Statins for Elevated hs-CRP
JUPITER randomized 17,802 apparently healthy people with LDL below 130 mg/dL and hs-CRP of 2.0 mg/L or higher to rosuvastatin or placebo. Rosuvastatin lowered LDL by 50% and hs-CRP by 37% and cut the combined cardiovascular endpoint (HR 0.56) over a median 1.9 years.
Source: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Exercise Lowers CRP
A meta-analysis of 83 controlled trials (3,769 participants) found exercise training lowered CRP (effect size 0.26). The drop was larger when BMI fell, but CRP also improved without weight loss.
CANTOS Trial: Targeting Inflammation
In 10,061 patients with prior myocardial infarction and hs-CRP of 2 mg/L or more, canakinumab 150 mg every 3 months lowered hs-CRP 37 percentage points more than placebo and reduced recurrent cardiovascular events (HR 0.85) without changing lipids. It increased fatal infections and did not change all-cause mortality.
Source: Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Which Providers Test hs-CRP (High Sensitivity C-Reactive Protein)?
Cheapest: Oura Health Panels at $99/year. Most comprehensive: Function Health, 160+ biomarkers for $365/year.
20 panels that include it, cheapest first
| Provider | Annual Cost | Total Biomarkers | $/Biomarker |
|---|---|---|---|
| $99 | 50 | $1.98 | |
| $190 | 100+ | $1.90 | |
| $297 | 100+ | $2.97 | |
 Labcorp OnDemand | $338 | 50+ | $6.76 |
 Superpower | $349 | 100+ | $3.49 |
| $349 | 75+ | $4.65 | |
 WHOOP Advanced Labs | $349 | 65 | $5.37 |
 Function Health | $365 | 160+ | $2.28 |
| $365 | 100+ | $3.65 | |
| $375 | 108 | $3.47 | |
| $449 | 83 | $5.41 | |
| $495 | 80+ | $6.19 | |
| $499 | 100+ | $4.99 | |
| $700 | 138 | $5.07 | |
| $829 | 54 | $15.35 | |
| $895 | 100+ | $8.95 | |
| $996 | 59 | $16.88 | |
| $1188 | 70+ | $16.97 | |
| $1198 | 40+ | $29.95 | |
| $1950 | 130+ | $15.00 |
$/Biomarker is annual cost divided by the panel's advertised biomarker count, not the price of this one test. We track 23 blood test providers (32 plans); 21 of those plans are itemized marker by marker. Compare all of them.
1 itemized panel does not include hs-CRP (High Sensitivity C-Reactive Protein)
11 providers not itemized in our matrix
We have not itemized these marker by marker (some sell tests one at a time), so this page cannot say whether they offer hs-CRP (High Sensitivity C-Reactive Protein). Check with them directly.
Life Extension Standard · Quest Health · Ultrahuman Blood Vision · Lifeforce · Hundred Health · Personalabs · Walk-In Lab · HealthLabs · WHOOP Specialized Panels · Marek Health Essential · Vitality Blueprint Upload
Experts discussing hs-CRP (High Sensitivity C-Reactive Protein)
Podcast episodes where clinicians and researchers cover this marker in depth. Curated by hand; an episode is listed only when the marker is a substantial topic, not a passing mention.
Frequently Asked Questions
What is the optimal range for hs-CRP (High Sensitivity C-Reactive Protein)?
Published positions differ: <1.0 mg/L low risk; 1-3 average; >3 high (AHA/CDC scientific statement on inflammatory markers (2003)); ≥2.0 mg/L is a risk-enhancing factor (2018 AHA/ACC cholesterol guideline). Named practitioners target: <0.5 mg/L (optimal), <1 mg/L (low risk) (Optimal DX); <1.0 mg/L (lower is generally better) (Life Extension); <1.0 mg/L (Tracey O'Shea (Kresser Institute)). Lab reference interval: Low risk: <1.0 mg/L, Average risk: 1.0-3.0 mg/L, High risk: >3.0 mg/L (Labcorp, CDC/AHA). That is what a lab report flags against, not an optimal target.
Which blood test providers include hs-CRP (High Sensitivity C-Reactive Protein)?
20 of the 21 blood testing panels we itemize marker by marker include hs-CRP (High Sensitivity C-Reactive Protein) in their panels. This biomarker is widely available across major providers.
Related: YouBoost rates lifestyle and supplement interventions by evidence; HRV Zone tracks recovery trends.
Medical Disclaimer
This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider about your specific health needs.
Last reviewed Sep 23, 2026 · First published Sep 30, 2025